Centurion Wealth Management’s iShares MSCI KLD 400 Social ETF DSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
1,682
-1,188
-41% -$163K 0.06% 253
2026
Q1
$348K Buy
2,870
+68
+2% +$8.69K 0.08% 207
2025
Q4
$361K Buy
2,802
+61
+2% +$7.79K 0.08% 197
2025
Q3
$345K Buy
2,741
+6
+0.2% +$725 0.08% 206
2025
Q2
$318K Sell
2,735
-93
-3% -$9.9K 0.09% 171
2025
Q1
$312K Hold
2,828
0.1% 151
2024
Q4
$312K Sell
2,828
-436
-13% -$48.7K 0.1% 151
2024
Q3
$355K Buy
+3,264
New +$342K 0.11% 133
2024
Q1
$337K Sell
3,346
-519
-13% -$49.6K 0.13% 111
2023
Q4
$352K Buy
3,865
+444
+13% +$37.7K 0.15% 105
2023
Q3
$279K Buy
3,421
+77
+2% +$6.53K 0.14% 107
2023
Q2
$281K Buy
+3,344
New +$266K 0.14% 116

Other funds holding DSI

Centurion Wealth Management's DSI Position: Q2 2026 in Review

Centurion Wealth Management reduced its iShares MSCI KLD 400 Social ETF (DSI) stake by 41% in Q2 2026, selling an estimated $163K and leaving 1,682 shares worth $240K. The position accounts for 0.06% of the portfolio, ranked #253.

Centurion Wealth Management first reported a position in DSI in Q2 2023 and has held it in 12 quarters since. The position peaked at $361K in Q4 2025. 102 funds tracked by Wall St. Rank hold DSI as of Q2 2026.

  • Centurion Wealth Management held 1,682 shares of iShares MSCI KLD 400 Social ETF worth $240K as of Q2 2026.
  • Centurion Wealth Management sold 1,188 iShares MSCI KLD 400 Social ETF shares in Q2 2026, an estimated $163K.
  • iShares MSCI KLD 400 Social ETF made up 0.06% of Centurion Wealth Management's portfolio in Q2 2026, its #253 holding.
  • Centurion Wealth Management first reported a position in iShares MSCI KLD 400 Social ETF in Q2 2023 and has held it in 12 quarters since.
  • Centurion Wealth Management's iShares MSCI KLD 400 Social ETF position peaked at $361K in Q4 2025.
  • 102 funds tracked by Wall St. Rank held iShares MSCI KLD 400 Social ETF as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.